Oncology & Cancer

Too much sitting tied to higher risk of colon polyps in men

(HealthDay)—Men who are more sedentary face a higher risk of recurring colon polyps, according to a new study, even if these men break up their downtime with bouts of recreational activities such as walking, jogging or ...

Oncology & Cancer

New cancer screening technology on its way to commercialization

A colon cancer screening test developed at the University of Alberta is on its way to commercialization and potential worldwide use, through a new collaboration with a leading Chinese research institute and a U of A spinoff ...

Oncology & Cancer

Estimating the risk of bowel cancer

Polyps in the mucosa of the colon are a common finding during screening colonoscopies. Some sub-groups of polyps are classed as precursors of bowel cancer. Until now, it has not been possible to precisely estimate the risk ...

Oncology & Cancer

Scientists learn how soy foods protect against colon cancer

University of Illinois scientists have evidence that lifelong exposure to genistein, a bioactive component in soy foods, protects against colon cancer by repressing a signal that leads to accelerated growth of cells, polyps, ...

Oncology & Cancer

Study confirms safety of colonoscopy

Colon cancer develops slowly. Precancerous lesions usually need many years to turn into a dangerous carcinoma. They are well detectable in an endoscopic examination of the colon called colonoscopy and can be removed during ...

Oncology & Cancer

Obama admin. tackles colonoscopy confusion

(AP)—The new health law requires that most insurance plans cover all costs for preventive care, including colon cancer screening.

Oncology & Cancer

Vaccine triggers immunity to prevent colon cancer

(Medical Xpress)—A first-of-its-kind vaccine developed by University of Pittsburgh Cancer Institute (UPCI) researchers successfully prompted the immune system to respond to early indications of colon cancer in people at ...

Medications

Gattex approved for short bowel syndrome

(HealthDay)—Gattex (teduglutide) has been approved by the U.S. Food and Drug Administration to treat nutritional problems caused by short bowel syndrome.

page 5 from 9